Academics called on GPs to ‘better target’ antibiotics for those at highest need after analysing data on millions of ...

Older people are less likely to be given antibiotics for common infections by their GP compared with younger adults, a new ...

If you deal with recurrent UTIs, a new FDA-approved antibiotic called Blujepa could offer another treatment option—especially ...

Doctors are prescribing antibiotics for tens of thousands of patients with infections, with little or no consideration of ...

This antibiotic is the first new FDA-approved medication for urinary tract infections in decades, and meets the need for new ...

Epidemiologists at the University of Manchester found certain patients are more or less likely to get prescribed antibiotics ...

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...

Drug rashes can be an unwanted side effect of many medications. Learn which medications can cause these skin reactions.

Researchers discover a new class of antibiotic that selectively targets Neisseria gonorrhoeae, the bacterium that causes gonorrhoea. These substances trigger a self-destruction program, which also ...

The first-of-its-kind in-depth bacterial evolutionary map could pave the way for the development of precision treatments for ...

The drug is a needed new option for treating uncomplicated UTIs, a common infection that’s becoming harder to treat as rates ...

Blujepa, which is made by the British pharmaceutical company GSK plc, is approved for the treatment of women and children ...